您当前位置：首页 > 国际期刊-ACS Pharmacology & Translational Science期刊投稿发表详细信息

ACS Pharmacology & Translational Science Q1

期刊收录：
ESCI
Scopus

基本信息

期刊ISSN：
2575-9108
期刊简拼：
ACS Pharmacol. Transl. Sci.
年发文章数：
153
E-ISSN：
Gold OA文章占比
17.82%
研究文章占比：
80.39%
是否OA：
Transformative (TJ转换期刊是订阅式/混合期刊，但是正在积极转为完全开放获取期刊。查看ACS说明。)
Jcr分区：
Q1
中科院分区：

出版信息

出版商：
American Chemical Society
涉及研究方向：
Medicine-Pharmacology (medical)
出版国家：
UNITED STATES
出版语言：
English
出版周期：
Monthly
出版年份：
2018

2023-2024最新影响因子:4.9
自引率:0.00%
五年影响因子:4.9
JCI期刊引文指标:1.42
h-index:暂无h-index数据
CiteScore:10.00

期刊关键词

1区 ESCI Scopus

期刊简介

ACS Pharmacology & Translational Science publishes high quality, innovative, and impactful research across the broad spectrum of biological sciences, covering basic and molecular sciences through to translational preclinical studies. Clinical studies that address novel mechanisms of action, and methodological papers that provide innovation, and advance translation, will also be considered. We give priority to studies that fully integrate basic pharmacological and/or biochemical findings into physiological processes that have translational potential in a broad range of biomedical disciplines. Therefore, studies that employ a complementary blend of in vitro and in vivo systems are of particular interest to the journal. Nonetheless, all innovative and impactful research that has an articulated translational relevance will be considered.

ACS Pharmacology & Translational Science does not publish research on biological extracts that have unknown concentration or unknown chemical composition.

Authors are encouraged to use the pre-submission inquiry mechanism to ensure relevance and appropriateness of research.

《ACS Pharmacology & Translational Science》期刊已被查看：次
期刊简写：ACS Pharmacol. Transl. Sci.

此期刊被最新的JCR期刊ESCI收录